1. Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 11 (November 2017) Authors: Catenacci, Daniel V T; Tebbutt, Niall C; Davidenko, Irina; Murad, André M; Al-Batran, Salah-Eddin; Ilson, David H; Tjulandin, Sergei; Gotovkin, Evengy; Karaszewska, Boguslawa; Bondarenko, Igor; Tejani, Mohamedtaki A; Udrea, Anghel A; Tehfe, Mustapha; De Vita, Ferdinando; Turkington, Cheryl; Tang,... Journal: Lancet oncology Issue: Volume 18:Issue 11(2017:Nov.) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015. Issue 5 (3rd May 2016) Authors: Price, Timothy J; Thavaneswaran, Subotheni; Burge, Matthew; Segelov, Eva; Haller, Daniel G; Punt, Cornelis JA; Arnold, Dirk; Karapetis, Christos S; Tebbutt, Niall C; Pavlakis, Nick; Gibbs, Peter; Shapiro, Jeremy D Journal: Expert review of anticancer therapy Issue: Volume 16:Issue 5(2016) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab in colorectal cancer: current and future directions. Issue 10 (October 2012) Authors: Yeung, Yvonne; Tebbutt, Niall C Journal: Expert review of anticancer therapy Issue: Volume 12:Issue 10(2012) Page Start: 1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Management of advanced gastric cancer. (April 2012) Authors: Price, Timothy J; Shapiro, Jeremy D; Segelov, Eva; Karapetis, Christos S; Pavlakis, Nick; Van Cutsem, Eric; Shah, Manish A; Kang, Yoon-Koo; Tebbutt, Niall C Journal: Expert review of gastroenterology & hepatology Issue: Volume 6:Number 2(2012) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluating the time toxicity of cancer treatment in the CCTG CO.17 randomized clinical trial (RCT). Issue 28 (1st October 2022) Authors: Gupta, Arjun; O'Callaghan, Christopher J.; Zhu, Liting; Jonker, Derek J.; Wong, Ralph; Colwell, Bruce; Moore, Malcolm J; Karapetis, Christos Stelios; Tebbutt, Niall C; Shapiro, Jeremy David; Tu, Dongsheng; Booth, Christopher M. Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology. (4th December 2021) Authors: Goldberg, Richard M; Adams, Richard; Buyse, Marc; Eng, Cathy; Grothey, Axel; André, Thierry; Sobrero, Alberto F; Lichtman, Stuart M; Benson, Al B; Punt, Cornelis J A; Maughan, Tim; Burzykowski, Tomasz; Sommeijer, Dirkje; Saad, Everardo D; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, ... Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 6(2022) Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer. (1st June 2021) Authors: Yin, Jun; Cohen, Romain; Jin, Zhaohui; Liu, Heshan; Pederson, Levi; Adams, Richard; Grothey, Axel; Maughan, Timothy S; Venook, Alan; Van Cutsem, Eric; Punt, Cornelis; Koopman, Miriam; Falcone, Alfredo; Tebbutt, Niall C; Seymour, Matthew T; Bokemeyer, Carsten; Rubio, Eduardo Diaz; Kaplan, Richard;... Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 12(2021) Page Start: 1705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 6 (June 2019) Authors: Eng, Cathy; Kim, Tae Won; Bendell, Johanna; Argilés, Guillem; Tebbutt, Niall C; Di Bartolomeo, Maria; Falcone, Alfredo; Fakih, Marwan; Kozloff, Mark; Segal, Neil H; Sobrero, Alberto; Yan, Yibing; Chang, Ilsung; Uyei, Anne; Roberts, Louise; Ciardiello, Fortunato Journal: Lancet oncology Issue: Volume 20:Issue 6(2019) Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Issue 12 (December 2016) Authors: Franko, Jan; Shi, Qian; Meyers, Jeffrey P; Maughan, Timothy S; Adams, Richard A; Seymour, Matthew T; Saltz, Leonard; Punt, Cornelis J A; Koopman, Miriam; Tournigand, Christophe; Tebbutt, Niall C; Diaz-Rubio, Eduardo; Souglakos, John; Falcone, Alfredo; Chibaudel, Benoist; Heinemann, Volker; Moen, ... Journal: Lancet oncology Issue: Volume 17:Issue 12(2016:Dec.) Page Start: 1709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013. Issue 12 (December 2014) Authors: Price, Timothy J; Segelov, Eva; Burge, Matthew; Haller, Daniel G; Tebbutt, Niall C; Karapetis, Christos S; Punt, Cornelis JA; Pavlakis, Nick; Arnold, Dirk; Gibbs, Peter; Shapiro, Jeremy D Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 12(2014) Page Start: 1477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗